News Headline Summary

AstraZeneca (AZN LN) says no boost from baseline in mean daily Opioid dose

- Co. announces results from long-term safety trial of Naloxegol in patients with Opioid induced constipation.

Reaction details (11:34)

- Co. shares unreactive, trades down 0.97% at GBP 29.49 last.

26 Feb 2013 - 11:31 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: